Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Target Price at $8.38

Key Points

• Bioceres Crop Solutions Corp. has a consensus rating of "Moderate Buy" from five research firms, with an average one-year price target of $8.3750.
• Institutional investors have shown significant interest, with Fourth Sail Capital LP increasing its holdings by 25.1% in the first quarter.
• Bioceres posted a quarterly earnings report showing revenue of $59.60 million, which was slightly below the consensus estimate of $61.80 million.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $8.3750.

Several research firms have weighed in on BIOX. Brookline Capital Management lowered Bioceres Crop Solutions from a "strong-buy" rating to a "hold" rating in a report on Thursday, August 21st. Oppenheimer cut their target price on Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating on the stock in a report on Tuesday, July 15th. Finally, Wall Street Zen lowered Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a report on Saturday, August 23rd.

Bioceres Crop Solutions Stock Up 0.2%

NASDAQ BIOX traded up $0.01 during trading on Friday, hitting $2.71. 219,285 shares of the company traded hands, compared to its average volume of 209,967. Bioceres Crop Solutions has a 12 month low of $2.60 and a 12 month high of $11.39. The business has a fifty day simple moving average of $3.76 and a 200 day simple moving average of $4.27. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $169.63 million, a P/E ratio of -19.32, a PEG ratio of 1.20 and a beta of 0.44.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently made changes to their positions in BIOX. Jones Financial Companies Lllp grew its position in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE grew its position in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after purchasing an additional 3,735 shares during the last quarter. Jump Financial LLC acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at about $72,000. Avanza Fonder AB acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $72,000. Finally, PDT Partners LLC acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $81,000. 17.68% of the stock is owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.